Maternal efficacy and safety outcomes in a randomized, controlled trial comparing insulin detemir with NPH insulin in 310 pregnant women with type 1 diabetes

Diabetes Care

Volumn 35, Issue 10, 2012, Pages 2012-2017

  Mathiesen, Elisabeth R ^a,b   Hod, Moshe ^c   Ivanisevic, Marina ^d   Garcia, Santiago Duran ^e   Brøndsted, Lise ^f   Jovanovič, Lois ^g   Damm, Peter ^a,b   McCance, David R ^h  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c TEL AVIV UNIVERSITY   (Israel)

^d KBC Zagreb   (Croatia)

^e HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^f NOVO NORDISK A S   (Denmark)

^g SANSUM DIABETES RESEARCH INSTITUTE   (United States)

^h ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN ASPART; INSULIN DETEMIR; ISOPHANE INSULIN;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETIC KETOACIDOSIS; DIABETIC RETINOPATHY; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INJECTION SITE REACTION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; METABOLIC DISORDER; MULTICENTER STUDY; NUTRITIONAL DISORDER; OPEN STUDY; PARALLEL DESIGN; PREGNANT WOMAN; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; WEIGHT GAIN;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN ASPART; INSULIN, ISOPHANE; INSULIN, LONG-ACTING; PREGNANCY; PREGNANCY IN DIABETICS;

EID: 84866653669     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-2264     Document Type: Article

References (9)

1. Mathiesen ER, Damm P, Jovanovič L, et al. Basal insulin analogues in diabetic pregnancy: a literature review and baseline results of a randomised, controlled trial in type 1 diabetes. Diabetes Metab Res Rev 2011;27:543-551
2. Mathiesen ER, Kinsley B, Amiel SA, et al.; Insulin Aspart Pregnancy Study Group. Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: a randomized trial of insulin aspart versus human insulin in 322 pregnant women. Diabetes Care 2007;30:771-776
3. Hod M, Damm P, Kaaja R, Visser GH, Dunne F, Demidova I, et al. Insulin Aspart Pregnancy Study Group. Fetal and perinatal outcomes in type 1 diabetes pregnancy: a randomized study comparing insulin aspart with human insulin in 322 subjects. Am J Obstet Gynecol 2008;198:186.e1-e7
4. Hermansen K, Fontaine P, Kukolja KK, Peterkova V, Leth G, Gall MA. Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes. Diabetologia 2004;47:622-629
5. Bartley PC, Bogoev M, Larsen J, Philotheou A. Long-term efficacy and safety of insulin detemir compared to neutral protamine Hagedorn insulin in patients with type 1 diabetes using a treat-to-target basal-bolus regimen with insulin aspart at meals: a 2-year, randomized, controlled trial. Diabet Med 2008;25:442-449
6. Rosenn BM, Miodovnik M, Holcberg G, Khoury JC, Siddiqi TA. Hypoglycemia: the price of intensive insulin therapy for pregnant women with insulin-dependent diabetes mellitus. Obstet Gynecol 1995;85:417-422
7. Evers IM, ter Braak EWMT, de Valk HW, van Der Schoot B, Janssen N, Visser GH. Risk indicators predictive for severe hypoglycemia during the first trimester of type 1 diabetic pregnancy. Diabetes Care 2002;25:554-559
8. ter Braak EW, Evers IM, Willem Erkelens D, Visser GH. Maternal hypoglycemia during pregnancy in type 1 diabetes: maternal and fetal consequences. Diabetes Metab Res Rev 2002;18:96-105
9. Nielsen LR, Pedersen-Bjergaard U, Thorsteinsson B, Johansen M, Damm P, Mathiesen ER. Hypoglycemia in pregnant women with type 1 diabetes: predictors and role of metabolic control. Diabetes Care 2008;31:9-14